HK1042237A1 - 緩釋組合物，製備該組合物的方法及其用途 - Google Patents

緩釋組合物，製備該組合物的方法及其用途

Info

Publication number
HK1042237A1
HK1042237A1 HK02103567.5A HK02103567A HK1042237A1 HK 1042237 A1 HK1042237 A1 HK 1042237A1 HK 02103567 A HK02103567 A HK 02103567A HK 1042237 A1 HK1042237 A1 HK 1042237A1
Authority
HK
Hong Kong
Prior art keywords
sustained release
release compositions
salt
producing
same
Prior art date
Application number
HK02103567.5A
Other languages
English (en)
Chinese (zh)
Inventor
Igari Yasutaka
Hata Yoshio
Yamamoto Kazumichi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of HK1042237A1 publication Critical patent/HK1042237A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK02103567.5A 1999-07-15 2002-05-11 緩釋組合物，製備該組合物的方法及其用途 HK1042237A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20188799 1999-07-15
PCT/JP2000/004683 WO2001005380A1 (fr) 1999-07-15 2000-07-13 Compositions a liberation lente, techniques de production et methodes d'utilisation

Publications (1)

Publication Number Publication Date
HK1042237A1 true HK1042237A1 (zh) 2002-08-09

Family

ID=16448493

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103567.5A HK1042237A1 (zh) 1999-07-15 2002-05-11 緩釋組合物，製備該組合物的方法及其用途

Country Status (21)

Country Link
US (2) US7265157B1 (xx)
EP (1) EP1197208B1 (xx)
KR (1) KR20020012312A (xx)
CN (1) CN1361685A (xx)
AT (1) ATE360413T1 (xx)
AU (1) AU5853000A (xx)
BR (1) BR0012400A (xx)
CA (1) CA2378714A1 (xx)
CZ (1) CZ2002114A3 (xx)
DE (1) DE60034568T2 (xx)
HK (1) HK1042237A1 (xx)
HU (1) HUP0202880A3 (xx)
IL (1) IL147417A0 (xx)
MX (1) MXPA02000461A (xx)
NO (1) NO20020084L (xx)
NZ (1) NZ516466A (xx)
PL (1) PL352499A1 (xx)
RU (1) RU2002103718A (xx)
SK (1) SK342002A3 (xx)
WO (1) WO2001005380A1 (xx)
ZA (1) ZA200200347B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1048301A4 (en) * 1998-01-16 2005-03-09 Takeda Chemical Industries Ltd COMPOSITIONS WITH DELAYED ACTIVE INGREDIENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE
PT1158014E (pt) 1998-12-15 2005-04-29 Takeda Pharmaceutical Processo para a producao de poliesteres biodegradaveis
WO2002012369A1 (fr) 2000-08-07 2002-02-14 Wako Pure Chemical Industries, Ltd. Polymere d'acide lactique et son procede de preparation
EP1374855A1 (en) * 2001-03-30 2004-01-02 Takeda Chemical Industries, Ltd. Medicinal solutions
US20040235748A1 (en) * 2001-04-25 2004-11-25 Yasutaka Igari Agents for preventing postoperative recurrence of premenopausal breast cancer
US6693134B2 (en) 2001-05-29 2004-02-17 Chemokine Therapeutics Corporation Bicyclic aromatic chemokine receptor ligands
AR034641A1 (es) * 2001-06-29 2004-03-03 Takeda Pharmaceutical Composicion de liberacion controlada y metodo para producirla
WO2003055470A1 (fr) * 2001-12-26 2003-07-10 Takeda Chemical Industries, Ltd. Nouvelle microsphere et son procede de production
CA2490351C (en) 2002-06-25 2011-11-01 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition
BRPI0412211A (pt) * 2003-07-23 2006-08-22 Pr Pharmaceuticals Inc composições de liberação controlada
US7906125B2 (en) 2003-09-18 2011-03-15 Boston Scientific Scimed, Inc. Solid or semi-solid therapeutic formulations
US20050064045A1 (en) * 2003-09-18 2005-03-24 Sheng-Ping Zhong Injectable therapeutic formulations
TW200529890A (en) 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
EP1679065A1 (en) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8263109B2 (en) 2005-05-09 2012-09-11 Boston Scientific Scimed, Inc. Injectable bulking compositions
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2007070563A2 (en) * 2005-12-13 2007-06-21 Harkness Pharmaceuticals, Inc. Stable solid forms of enterostatin
JP2009523122A (ja) * 2005-12-13 2009-06-18 ハルクネスス プハルマセウティカルス，インコーポレイテッド エンテロスタチンを使用して肥満を治療する方法
JP2009542813A (ja) * 2006-07-11 2009-12-03 ハルクネスス プハルマセウティカルス，インコーポレイテッド 飽食因子を使用して肥満を治療する方法
US7858663B1 (en) * 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
NZ577281A (en) 2006-12-18 2011-12-22 Takeda Pharmaceutical Sustained-release composition and method for producing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use
ES2221019T3 (es) 1996-10-31 2004-12-16 Takeda Chemical Industries, Ltd. Preparacion de liberacion mantenida.
AU5678398A (en) 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
EP1048301A4 (en) * 1998-01-16 2005-03-09 Takeda Chemical Industries Ltd COMPOSITIONS WITH DELAYED ACTIVE INGREDIENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE
JPH11269094A (ja) * 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途
PT1158014E (pt) 1998-12-15 2005-04-29 Takeda Pharmaceutical Processo para a producao de poliesteres biodegradaveis

Also Published As

Publication number Publication date
NO20020084L (no) 2002-03-14
ZA200200347B (en) 2003-03-26
NO20020084D0 (no) 2002-01-08
BR0012400A (pt) 2002-05-21
CA2378714A1 (en) 2001-01-25
US7265157B1 (en) 2007-09-04
RU2002103718A (ru) 2003-10-10
SK342002A3 (en) 2002-05-09
DE60034568D1 (de) 2007-06-06
HUP0202880A2 (hu) 2003-01-28
EP1197208A4 (en) 2004-06-30
ATE360413T1 (de) 2007-05-15
EP1197208B1 (en) 2007-04-25
US20080014237A1 (en) 2008-01-17
MXPA02000461A (es) 2002-07-30
NZ516466A (en) 2003-02-28
HUP0202880A3 (en) 2003-04-28
PL352499A1 (en) 2003-08-25
EP1197208A1 (en) 2002-04-17
AU5853000A (en) 2001-02-05
CN1361685A (zh) 2002-07-31
WO2001005380A1 (fr) 2001-01-25
KR20020012312A (ko) 2002-02-15
DE60034568T2 (de) 2008-01-03
IL147417A0 (en) 2002-08-14
CZ2002114A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
HK1042237A1 (zh) 緩釋組合物，製備該組合物的方法及其用途
HUP0100221A2 (hu) Nyújtott hatású készítmény és eljárás az előállítására, valamint alkalmazása
HK1095526A1 (zh) 乳酸聚合物及其製備方法
LTIP442A (en) Prolonged release pharmaceutical preparation, polymeric composition as base for it and process for preparing thereof
WO2001019780A3 (de) Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
WO1999057301A8 (fr) Composes dont la structure comporte des derives d'acide glucuronique et des derives de glucosamine, leur procede de preparation et d'utilisation
MY139606A (en) Sustained-release composition and process for producing the same
WO2001019776A3 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
CA2334775A1 (en) Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
HK1089459A1 (en) Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and use
HUT60740A (en) Process for producing new thiophnecarboxylic acid esters of amino-alcohols, their quaternary derivatives and pharmaceutical compositions comprising same as active ingredient
PL354004A1 (en) Novel dicarboxylic acid derivatives with pharmaceutical properties
EP1076055A4 (en) 1- (1-SUBSTITUTED-4-PIPERIDINYL) METHYL] -4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND INTERMEDIATES THEREOF
MY142066A (en) Controlled release composition comprising lactic acid polymer, and method of producing the same
CA2253997A1 (en) Phosphonic acid-substituted benzazepinone-n-acetic acid derivatives, processes for their preparation and pharmaceutical compositions comprising them
AU6834000A (en) Carboxylic acid amides, their production and their use as drugs
EP0506979A4 (en) Organic polymer compound and production thereof
JP4699635B2 (ja) 徐放性薬剤組成物
US20030129232A1 (en) Biologically absorbable polyhydroxycarboxylic acid and production method thereof
CA2164276A1 (en) New highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
MXPA00004698A (es) Sintesis del 5,5'-diformil 2,2'-difurano y sus derivados.